Test Code FSJCV STRATIFY JCV AB (w/ Index) w/ Reflex to Inhibition Assay
Useful For
Used to aid in the stratification of risk for the development of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients receiving or considering TYSABRI® (natalizumab) therapy.
Specimen Information
Obtain specimen using standard phlebotomy techniques.
No special patient preparation is necessary.
| Container | Specimen | Temperature | Collect Vol | Submit Vol | Min Vol | Stability |
| SST | Serum | Room Temp | 4 mL | 1.0 mL | 0.6 mL | 7 Days |
| EDTA | Plasma | Room Temp | 3 mL | 1.0 mL | 0.6 mL | 7 Days |
Reject Due To:
- Moderate or Marked Hemolysis
- Specimen unlabeled or mislabeled
Reference Range
Negative
Test Schedule / Analytic Time / Test Priority
Mon - Sat / 2 - 5 days / NOT available STAT
Method
Immunoassay
CPT / LOINC
| Meditech | Medent | LOINC | CPT |
| FSJCV (Antibody) | FSJCV | 70173-0 | 86711 |
| Index Value | N/A | 100977-8 |